Georgia
Provider Communications
Anthem clinical criteria updates for specialty pharmacy are available
Access the clinical criteria document information.
Anthem’s prior authorization clinical review of non-oncology specialty pharmacy drugs will be managed by Anthem’s medical specialty drug review team. Drugs used for the treatment of Oncology will be managed by AIM Specialty Health® (AIM), a separate company
ING-CC-0062 |
Tumor Necrosis Factor Antagonists |
ING-CC-0078 |
Orencia (abatacept) |
ING-CC-0207 |
Vyvgart (efgartigimod alfa-fcab) |
ING-CC-0208 |
Adbry (tralokinumab) |
ING-CC-0209 |
Leqvio (inclisiran) |
Featured In:
March 2022 Anthem Provider News - Georgia